Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China
· Delayed Price · Currency is CNY 3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST
SHA:600664 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,268 | 8,689 | 10,401 | 8,445 | 7,599 | 8,940 | Upgrade
|
| Market Cap Growth | 0.55% | -16.46% | 23.17% | 11.14% | -15.00% | 11.79% | Upgrade
|
| Enterprise Value | 8,082 | 7,944 | 9,834 | 8,373 | 8,608 | 10,444 | Upgrade
|
| Last Close Price | 3.68 | 3.45 | 4.13 | 3.35 | 3.01 | 3.55 | Upgrade
|
| PE Ratio | 30.75 | 24.03 | 16.54 | 21.37 | 16.34 | 24.09 | Upgrade
|
| Forward PE | - | 14.91 | 14.91 | 14.91 | 14.91 | 14.91 | Upgrade
|
| PS Ratio | 0.58 | 0.54 | 0.64 | 0.55 | 0.55 | 0.70 | Upgrade
|
| PB Ratio | 1.40 | 1.35 | 1.71 | 1.56 | 1.54 | 2.02 | Upgrade
|
| P/TBV Ratio | 1.71 | 1.66 | 2.12 | 2.00 | 1.98 | 2.69 | Upgrade
|
| P/FCF Ratio | 16.38 | 30.10 | 15.04 | 9.78 | 14.27 | - | Upgrade
|
| P/OCF Ratio | 12.91 | 19.76 | 13.13 | 8.89 | 12.22 | - | Upgrade
|
| EV/Sales Ratio | 0.51 | 0.50 | 0.61 | 0.54 | 0.62 | 0.82 | Upgrade
|
| EV/EBITDA Ratio | 8.76 | 8.28 | 9.23 | 9.53 | 10.48 | 14.57 | Upgrade
|
| EV/EBIT Ratio | 11.88 | 10.88 | 11.57 | 13.54 | 15.43 | 23.33 | Upgrade
|
| EV/FCF Ratio | 14.28 | 27.52 | 14.22 | 9.70 | 16.17 | - | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.19 | 0.29 | 0.34 | 0.44 | 0.52 | Upgrade
|
| Debt / EBITDA Ratio | 1.32 | 1.28 | 1.58 | 2.01 | 2.48 | 3.06 | Upgrade
|
| Debt / FCF Ratio | 2.16 | 4.31 | 2.55 | 2.15 | 4.04 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.30 | -0.34 | -0.31 | -0.22 | -0.06 | 0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.15 | -2.29 | -1.76 | -1.37 | -0.35 | 1.01 | Upgrade
|
| Net Debt / FCF Ratio | -3.47 | -7.60 | -2.71 | -1.39 | -0.53 | -3.01 | Upgrade
|
| Asset Turnover | 1.11 | 1.11 | 1.13 | 1.12 | 1.05 | 1.04 | Upgrade
|
| Inventory Turnover | 5.98 | 5.98 | 6.11 | 6.14 | 5.40 | 5.01 | Upgrade
|
| Quick Ratio | 1.12 | 1.12 | 1.08 | 0.99 | 0.93 | 0.82 | Upgrade
|
| Current Ratio | 1.45 | 1.44 | 1.36 | 1.26 | 1.20 | 1.11 | Upgrade
|
| Return on Equity (ROE) | 5.27% | 6.35% | 12.00% | 9.15% | 10.94% | 9.75% | Upgrade
|
| Return on Assets (ROA) | 2.96% | 3.16% | 3.70% | 2.81% | 2.65% | 2.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.23% | 11.99% | 15.90% | 10.15% | 8.31% | 5.82% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.70% | 10.60% | 13.10% | 10.50% | 10.30% | 9.00% | Upgrade
|
| Earnings Yield | 3.34% | 4.16% | 6.05% | 4.68% | 6.12% | 4.15% | Upgrade
|
| FCF Yield | 6.11% | 3.32% | 6.65% | 10.22% | 7.01% | -2.67% | Upgrade
|
| Payout Ratio | 8.17% | 9.21% | 7.49% | 11.17% | 11.68% | 16.59% | Upgrade
|
| Buyback Yield / Dilution | -1.54% | -2.68% | -1.82% | 4.40% | -4.46% | 1.29% | Upgrade
|
| Total Shareholder Return | -1.54% | -2.68% | -1.82% | 4.40% | -4.46% | 1.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.